Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q4 2023 Earnings

2NovConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.45

-0.3

-0.14

0.01

Details

Expected EPS

-0.45

Actual EPS

-0.4

Surprise EPS

0.05

Surprise Percent

+11.11%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.4 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.